CBIO · trading date Oct 13, 2026 · previous close $14.47 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$10.84M
Net income
-$153.94M
Total assets
$240.29M
Total liabilities
$37.28M
Stockholders' equity
$203.01M
Cash & equivalents
$213.19M
Operating income
-$152.63M
Operating cash flow
-$71.53M
Capital expenditures
$919.0K
Fiscal year 2025, via 10-K filed 2026-02-26.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-1,407.5%
Net margin
-1,419.6%
Free cash flow
-$72.45M
Free cash flow margin
-668.1%
Liabilities / assets
15.5%
Equity / assets
84.5%
CapEx / revenue
8.5%
Operating cash flow / net income
0.46×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Waltham, MA 02451
300 FIFTH AVENUE
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.